Clinical and metabolic aspects of continuous ambulatory peritoneal dialysis (CAPD).
Experience with CAPD in 14 patients, treated for periods of 2-10 months, is presented. Clinical and biochemical control of uremia appeared adequate in all patients except one. Control of extracellular volume and hypertension was easier with CAPD than with intermittent peritoneal dialysis (IPD). Nine episodes of peritonitis occurred in 5 patients (one peritonitis/8 patients months). Mean protein loss was 9.7 +/- 2.7 g per day. In 6 patients on IPD oral glucose tolerance test resulted in a paradoxical rise of HGH, whereas this was not observed after 4 months of CAPD.
D000328:Adult; D000368:Aged; D000553:Ambulatory Care; D001774:Blood Chemical Analysis; D050260:Carbohydrate Metabolism; D005260:Female; D005947:Glucose / Q000494:pharmacology*; D005951:Glucose Tolerance Test; D006801:Humans; D050356:Lipid Metabolism; D008297:Male; D008875:Middle Aged; D010530:Peritoneal Dialysis / Q000379:methods*; D010538:Peritonitis / Q000209:etiology; D011506:Proteins / Q000032:analysis
D011506:Proteins; D005947:Glucose